TransMedics (TMDX) Total Current Liabilities (2018 - 2026)

TransMedics' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $91.9 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 65.31% year-over-year to $91.9 million in Q1 2026; TTM through Mar 2026 was $91.9 million, a 65.31% increase from a year earlier, with the FY2025 full-year figure at $89.3 million, up 49.06% from the prior year.
• Total Current Liabilities grew to $91.9 million in Q1 2026 per TMDX's latest filing, from $89.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $91.9 million in Q1 2026 and bottomed at $20.3 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $54.3 million (2024), against an average of $50.0 million.
• Across the five-year window, Total Current Liabilities grew 1.82% in 2022 and jumped 137.33% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $23.7 million in 2022, then surged by 132.17% to $54.9 million in 2023, then grew by 9.06% to $59.9 million in 2024, then soared by 49.06% to $89.3 million in 2025, then advanced by 2.93% to $91.9 million in 2026.
• Per Business Quant, the three latest TMDX Total Current Liabilities figures stand at $91.9 million (Q1 2026), $89.3 million (Q4 2025), and $79.7 million (Q3 2025).